Sanyou

Sanyou Medical Co., Ltd is a Chinese corporation founded in 2005, specializing in the R&D, manufacturing, and sales of innovative orthopedic products. The company's focus is on spinal and trauma implants, and it is one of the few in China with the capacity for original innovations in this field. Led by Dr. Michael Mingyan Liu, the company has established a robust product development system and possesses advanced R&D equipment, receiving 22 Class III medical device registration certificates and 131 patents by January 2021. Notably, the company's stock symbol is 688085. Furthermore, Sanyou Medical has been honored with various awards and distinctions, including the first prize of Science Progress Award and recognition as a Pilot Enterprise of Patent Work in Shanghai. In 2017, the company secured a CNY 100 million Private Equity Round investment from Yingke Capital. With plans to increase R&D investment continually, Sanyou aims to maintain its leadership in the Chinese spinal implants market, leveraging the opportunity presented by being listed on the Science and Technology Innovation Board to foster innovation in domestic medical device products. This strategic approach aligns with the company's goal of achieving substantial market share growth.